Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000081976 | SCV000113911 | benign | not specified | 2015-04-03 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000081976 | SCV000596033 | likely benign | not specified | 2016-05-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313814 | SCV000847558 | likely benign | Inborn genetic diseases | 2016-01-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003964941 | SCV004779864 | likely benign | NLGN3-related disorder | 2019-08-27 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |